Intrapleural combination therapy with lobaplatin and erythromycin for non‐small cell lung cancer‐mediated malignant pleural effusion

BACKGROUND: Malignant pleural effusion is a common complication of non‐small cell lung cancer (NSCLC); however, treatment options remain limited. This study evaluated the safety and efficacy of sequential intrapleural therapy with lobaplatin and erythromycin for NSCLC‐mediated malignant pleural effu...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Lisheng, Wang, Benjie, Gao, Meimei, Zhang, Yan, Qi, Qian, Li, Tao, Li, Caiyu, Wang, Aihua, Li, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068459/
https://www.ncbi.nlm.nih.gov/pubmed/29917319
http://dx.doi.org/10.1111/1759-7714.12768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068459/
https://www.ncbi.nlm.nih.gov/pubmed/29917319
http://dx.doi.org/10.1111/1759-7714.12768

Ejemplares similares